Use of High-Resolution Accurate Mass Spectrometry to Detect Reported and Previously Unreported Cannabinomimetics in "Herbal High" Products

被引:103
作者
Hudson, Simon [1 ]
Ramsey, John [2 ]
King, Les
Timbers, Sarah [1 ]
Maynard, Steve [1 ]
Dorgan, Paul I. [3 ]
Wood, David M. [3 ]
机构
[1] HFL Sport Sci, Fordham CB7 5WW, Cambs, England
[2] St Georges Univ London, TICTAC Commun Ltd, London SW17 0RE, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
关键词
CANNABIMIMETIC INDOLES; CB1; CLASSIFICATION; PHARMACOLOGY; SPICE;
D O I
10.1093/jat/34.5.252
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A range of "Herbal High" products were tested for synthetic cannabinoids (cannabinomimetics) to qualitatively determine and compare their individual and relative content. Liquid chromatography-high resolution accurate mass spectrometry was used to rapidly screen samples for a range of cannabinomimetics using mono-isotopic masses derived from the elemental composition of target analytes. A screening database of over 140 compounds was rapidly created. This approach, combined with further tandem mass spectrometric experiments, also facilitated the detection and identification of compounds for which reference materials were not available. Previously reported cannabinomimetics, including JWH-018 and CP47,497 and its homologues, were detected in varying relative proportions along with several tentatively identified unreported cannabinomimetics. In some countries, the decision has been made to include these substances within their drug control legislation, and other countries are considering similar action. The currently applied drug screening techniques are unlikely to be effective in providing scientific evidence to support their identification in seized products. The application of high-resolution accurate mass spectrometry offers a solution. In addition, the technology provides a relatively simple and quick method for screening products, building substance databases, and even identifying novel substances using a combination of accurate mass derived elemental composition and fragment ions combined with fragmentation prediction software.
引用
收藏
页码:252 / 260
页数:9
相关论文
共 18 条
  • [1] Advisory Council on the Misuse of Drugs, 2009, CONS MAJ CANN AG
  • [2] [Anonymous], 2009, MICROGRAM B, V42, P23
  • [3] Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
    Aung, MM
    Griffin, G
    Huffman, JW
    Wu, MJ
    Keel, C
    Yang, B
    Showalter, VM
    Abood, ME
    Martin, BR
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) : 133 - 140
  • [4] 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
    Auwaerter, Volker
    Dresen, Sebastian
    Weinmann, Wolfgang
    Mueller, Michael
    Puetz, Michael
    Ferreiros, Nerea
    [J]. JOURNAL OF MASS SPECTROMETRY, 2009, 44 (05): : 832 - 837
  • [5] COMPTON DR, 1993, J PHARMACOL EXP THER, V265, P218
  • [6] COMPTON DR, 1992, J PHARMACOL EXP THER, V260, P201
  • [7] International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    Howlett, AC
    Barth, F
    Bonner, TI
    Cabral, G
    Casellas, P
    Devane, WA
    Felder, CC
    Herkenham, M
    Mackie, K
    Martin, BR
    Mechoulam, R
    Pertwee, RG
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 161 - 202
  • [8] Huffman John W., 2009, P49, DOI 10.1007/978-1-59745-503-9_3
  • [9] Structure-activity relationships for 1-alkyl-3-(l-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors:: steric and electronic effects of naphthoyl substituents.: New highly selective CB2 receptor agonists
    Huffman, JW
    Zengin, G
    Wu, MJ
    Lu, JZ
    Hynd, G
    Bushell, K
    Thompson, ALS
    Bushell, S
    Tartal, C
    Hurst, DP
    Reggio, PH
    Selley, DE
    Cassidy, MP
    Wiley, JL
    Martin, BR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (01) : 89 - 112
  • [10] 3-indolyl-1-naphthylmethanes:: New cannabimimetic Indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor
    Huffman, JW
    Mabon, R
    Wu, MJ
    Lu, JZ
    Hart, R
    Hurst, DP
    Reggio, PH
    Wiley, JL
    Martin, BR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) : 539 - 549